ILLUMINA, INC. 8-K

What Happened
Illumina, Inc. announced on January 13, 2026 that it issued a press release reporting unaudited preliminary financial results for the fourth quarter and fiscal year ended December 28, 2025. The announcement was made in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference in San Francisco; the webcast is available via the company’s Investor Relations website and will remain accessible for at least 30 days. The press release is furnished as Exhibit 99.1 to the Form 8‑K pursuant to General Instruction F.

Key Details

• Filing date: January 13, 2026 (Form 8‑K Item 2.02 and Item 9.01).
• Period covered: Fourth quarter and fiscal year ended December 28, 2025.
• Materials: Press release with unaudited preliminary results attached as Exhibit 99.1.
• Webcast: Presentation at the J.P. Morgan Healthcare Conference; archived on Illumina’s Investor Relations site for ≥30 days.

Why It Matters
Retail investors should review the furnished press release and the webcast for the company’s latest earnings and revenue signals, as preliminary quarterly and full‑year results can affect expectations for guidance, profitability, and cash flow. Because the figures are described as unaudited and preliminary, final audited results in future SEC filings or earnings releases may differ. Check Illumina’s Investor Relations page and subsequent SEC filings for the finalized financial statements and management commentary.